Literature DB >> 14685157

UV irradiation inhibits ABC transporters via generation of ADP-ribose by concerted action of poly(ADP-ribose) polymerase-1 and glycohydrolase.

I E Dumitriu1, R E Voll, W Kolowos, U S Gaipl, P Heyder, J R Kalden, M Herrmann.   

Abstract

ATP-binding cassette (ABC) transporters are involved in the transport of multiple substrates across cellular membranes, including metabolites, proteins, and drugs. Employing a functional fluorochrome export assay, we found that UVB irradiation strongly inhibits the activity of ABC transporters. Specific inhibitors of poly(ADP-ribose) polymerase-1 (PARP-1) restored the function of ABC transporters in UVB-irradiated cells, and PARP-1-deficient cells did not undergo UVB-induced membrane transport inhibition. These data suggest that PARP-1 activation is necessary for ABC transporter functional downregulation. The hydrolysis of poly(ADP-ribose) by poly(ADP-ribose) glycohydrolase (PARG) was also required, since specific PARG inhibitors, which limit the production of ADP-ribose molecules, restored the function of ABC transporters. Furthermore, ADP-ribose molecules potently inhibited the activity of the ABC transporter P-glycoprotein. Hence, poly(ADP-ribose) metabolism appears to play a novel role in the regulation of ABC transporters.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14685157     DOI: 10.1038/sj.cdd.4401348

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  10 in total

1.  Mono-galloyl glucose derivatives are potent poly(ADP-ribose) glycohydrolase (PARG) inhibitors and partially reduce PARP-1-dependent cell death.

Authors:  L Formentini; P Arapistas; M Pittelli; M Jacomelli; V Pitozzi; S Menichetti; A Romani; L Giovannelli; F Moroni; A Chiarugi
Journal:  Br J Pharmacol       Date:  2008-09-22       Impact factor: 8.739

Review 2.  PARP inhibitors and more.

Authors:  Chinmoy K Bose; Nirban Basu
Journal:  J Turk Ger Gynecol Assoc       Date:  2015-06-01

3.  [An impaired detection and clearance of dying cells can lead to the development of chronic autoimmunity].

Authors:  L E Munoz; M Herrmann; U S Gaipl
Journal:  Z Rheumatol       Date:  2005-09       Impact factor: 1.372

Review 4.  Mitochondrial dysfunction and NAD(+) metabolism alterations in the pathophysiology of acute brain injury.

Authors:  Katrina Owens; Ji H Park; Rosemary Schuh; Tibor Kristian
Journal:  Transl Stroke Res       Date:  2013-08-10       Impact factor: 6.829

Review 5.  Redox modulation of HMGB1-related signaling.

Authors:  Christina Janko; Milos Filipović; Luis E Munoz; Christine Schorn; Georg Schett; Ivana Ivanović-Burmazović; Martin Herrmann
Journal:  Antioxid Redox Signal       Date:  2013-03-19       Impact factor: 8.401

6.  Bioenergetic metabolites regulate base excision repair-dependent cell death in response to DNA damage.

Authors:  Jiang-bo Tang; Eva M Goellner; Xiao-hong Wang; Ram N Trivedi; Claudette M St Croix; Elena Jelezcova; David Svilar; Ashley R Brown; Robert W Sobol
Journal:  Mol Cancer Res       Date:  2010-01-12       Impact factor: 5.852

7.  Hydrolase regulates NAD+ metabolites and modulates cellular redox.

Authors:  Lei Tong; Susan Lee; John M Denu
Journal:  J Biol Chem       Date:  2009-02-27       Impact factor: 5.157

8.  ABCB1 (MDR1) induction defines a common resistance mechanism in paclitaxel- and olaparib-resistant ovarian cancer cells.

Authors:  Aparajitha Vaidyanathan; Lynne Sawers; Anne-Louise Gannon; Probir Chakravarty; Alison L Scott; Susan E Bray; Michelle J Ferguson; Gillian Smith
Journal:  Br J Cancer       Date:  2016-07-14       Impact factor: 7.640

9.  Positive selection in Europeans and East-Asians at the ABCA12 gene.

Authors:  Roberto Sirica; Marianna Buonaiuto; Valeria Petrella; Lucia Sticco; Donatella Tramontano; Dario Antonini; Caterina Missero; Ombretta Guardiola; Gennaro Andolfi; Heerman Kumar; Qasim Ayub; Yali Xue; Chris Tyler-Smith; Marco Salvemini; Giovanni D'Angelo; Vincenza Colonna
Journal:  Sci Rep       Date:  2019-03-19       Impact factor: 4.379

10.  Resistance to PARP-Inhibitors in Cancer Therapy.

Authors:  Alicia Montoni; Mihaela Robu; Emilie Pouliot; Girish M Shah
Journal:  Front Pharmacol       Date:  2013-02-27       Impact factor: 5.810

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.